schizophrenia

IPO initial public offering Wall Street
Biotech

Big Pharma-backed MapLight plots IPO

Should the listing go through, MapLight would become just the second biotech to go public since February.
Darren Incorvaia Sep 22, 2025 1:57pm
Money frozen in ice

CNS biotech attempts to break the IPO ice

Aug 25, 2025 11:10am
colorful brain art model

Atai's schizophrenia drug fails to improve cognition in phase 2

Jul 28, 2025 7:45am
The Top Line

What were the biggest clinical trial flops of 2024?

Feb 21, 2025 9:00am
Graphic showing arrows missing the bullseye on a target

2024's top 10 clinical trial flops

Feb 18, 2025 3:00am
balloon missed target pop arrows miss failure

Boehringer's schizophrenia drug fails trio of phase 3 trials

Jan 16, 2025 11:58am